FAPi-Mediated siRNA Lipid Nanoparticles for the Treatment of Liver Fibrosis.
- DOI
- 10.1002/smll.75839
- Published
- 2026 Sep 17
- Container
- Small (Weinheim an der Bergstrasse, Germany)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/smll.75839,
title = {FAPi-Mediated siRNA Lipid Nanoparticles for the Treatment of Liver Fibrosis.},
author = {Feng R and Zhu S and Yao Z and Li J and Feng Y and Zhou Z and Wang J and Lu W and Liu Y and Zhan C and Yu J and Sun L and Jiang K and Yan Z},
year = {2026},
journal = {Small (Weinheim an der Bergstrasse, Germany)},
doi = {10.1002/smll.75839},
url = {https://doi.org/10.1002/smll.75839}
}RIS
TY - JOUR TI - FAPi-Mediated siRNA Lipid Nanoparticles for the Treatment of Liver Fibrosis. AU - Feng R AU - Zhu S AU - Yao Z AU - Li J AU - Feng Y AU - Zhou Z AU - Wang J AU - Lu W AU - Liu Y AU - Zhan C AU - Yu J AU - Sun L AU - Jiang K AU - Yan Z PY - 2026 JO - Small (Weinheim an der Bergstrasse, Germany) DO - 10.1002/smll.75839 UR - https://doi.org/10.1002/smll.75839 ER -
APA
R, F., S, Z., Z, Y., J, L., Y, F., Z, Z., J, W., W, L., Y, L., C, Z., J, Y., L, S., K, J., & Z, Y. (2026). FAPi-Mediated siRNA Lipid Nanoparticles for the Treatment of Liver Fibrosis.. Small (Weinheim an der Bergstrasse, Germany). https://doi.org/10.1002/smll.75839
Source records
- pubmed · retrieved 2026-09-24T23:08:14.407Z